These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 31912450)

  • 21. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9-mediated genome editing of splicing mutation causing congenital hearing loss.
    Ryu N; Kim MA; Choi DG; Kim YR; Sonn JK; Lee KY; Kim UK
    Gene; 2019 Jun; 703():83-90. PubMed ID: 30898719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
    Peddle CF; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene editing in a Myo6 semi-dominant mouse model rescues auditory function.
    Xue Y; Hu X; Wang D; Li D; Li Y; Wang F; Huang M; Gu X; Xu Z; Zhou J; Wang J; Chai R; Shen J; Chen ZY; Li GL; Yang H; Li H; Zuo E; Shu Y
    Mol Ther; 2022 Jan; 30(1):105-118. PubMed ID: 34174443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Synergy between CRISPR and Chemical Engineering.
    Lau CH; Tin C
    Curr Gene Ther; 2019; 19(3):147-171. PubMed ID: 31267870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review.
    Babačić H; Mehta A; Merkel O; Schoser B
    PLoS One; 2019; 14(2):e0212198. PubMed ID: 30794581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas System for Genome Editing: Progress and Prospects as a Therapeutic Tool.
    Sahel DK; Mittal A; Chitkara D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):725-735. PubMed ID: 31122933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 39. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
    Muramoto T; Iriki H; Watanabe J; Kawata T
    Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes.
    Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A
    Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.